ArticlePDF Available
Editorial
Styliani Loukatou1, Paraskevas Fakourelis1, Louis Papageorgiou1,2, Vasileios Megalooikonomou3, Sophia
Kossida1 and Dimitrios Vlachakis1,3
1 Computational Biology & Medicine Group, Biomedical Research Foundation, Academy of Athens, Soranou Efessiou 4,
Athens 11527, Greece
2 Department of Informatics and Telecommunications, National and Kapodistrian University of Athens, University Campus,
Athens, 15784, Greece
3 Computer Engineering and Informatics Department, School of Engineering, University of Patras, 26500 Patras, Greece
Correspondence should be addressed to Dimitrios Vlachakis; Phone: +30 210 6597199, Fax: +30 210 6597545, Email:
dvlachakis@bioacademy.gr
Ebola virus epidemic: a deliberate accident?
The Ebola outbreak
As a new outbreak of Ebola virus has recently taken
place, it is vital that scientists take several steps to-
wards its combat. The Ebola Hemorrhagic Fever out-
break of 2014 is listed as the biggest one in history
with almost 9000 reported human cases and a 53% rate
of fatality. The Ebola virus is classified in the genus of
Ebolovirus, in the family of Filoviridae and order
Mononegavirales (Kuhn et al. 2010). Five viruses of
this class are known to be disease-causing in humans;
Zaire ebolavirus (EBOV), Sudan ebolavirus (SUDV),
Reston ebolavirus (RESTV), Côte d’Ivoire ebolavirus
(TAFV) and Uganda ebolavirus (BDBV). In the case
of the current outbreak, all listed cases have been in-
fected by EBOV. The latter is the most lethal of all. It
was named after the fact that the first formal record
was made in Zaire in 1976, presenting an 88% rate of
fatality; even though 2014’s outbreak is estimated to
be the deadliest Ebola outbreak by far (Gire et al.
2014).
Since 1976, humanity has been compelled to
face Ebola’s disease cases on an approximately annual
basis. At the beginning of the appearance of the dis-
ease, there were cases caused by all viruses’ species.
However, with the passage of time the viruses with the
low fatality rate disappeared. Is this a phenomenon of
natural selection or an artificial outcome? Can we di-
agnose any pattern in this statistical data?
Additionally, the mortality rate has always
increased in underdeveloped countries, probably due to
the lack of an organized health care system. During all
these years the number of human cases has been fluc-
tuating between 1 and 500. The Ebola’s outbreak,
which started in Guinea in December 2013 and spread
among Liberia, Sierra Leone, Nigeria, Senegal and
almost all the West African countries, admeasures
8469 human cases to date (Figure 1). The epidemic
soon spread in the Democratic Republic of Congo and
is still ongoing, with scientists predicting that the cases
could reach the number of 1.4 million by January
(Prevention, October 13, 2014).
Europe and the United States have had the
confidence that Ebola will not spread among their ter-
ritory. Nevertheless, on September 30, the first Ebola
case was diagnosed in Dallas, Texas (McCarthy 2014).
As for the European countries, the first recorded hu-
man case with Ebola was a Spanish missionary who
contracted the virus in Liberia (Gulland 2014). Ger-
many has also recorded the third patient of this deadly
disease and the first human death on October 14. Ac-
cording to the World Health Organization (WHO) in
August 2014, 10241 travelers originating from Sierra
Leone, Guinea and Liberia travelled to European coun-
tries. In addition, large numbers of migrant workers
from the outbreak area are located within Europe and
the US.
The epidemic has not made its presence felt in
Greece yet. However, Reuters reported a scientific re-
search that predicts a 75 percent chance of the virus
being imported into France and a 50 percent chance
into Great Britain by the end of October (Gomes, Sep
2014). Ebola outbreak is expected to accelerate in Oc-
tober 2014 with the number of projected cases touch-
ing the 14000.
Nevertheless, researchers are absolutely confi-
dent that Europe and America will not experience the
nightmare of Ebola’s outbreak. This seems justifiable,
as nearly all of the human cases in developed countries
have been healed. Whoever seeks conspiracy theories
may claim that these countries already have the cure
and that what is taking place in Africa is merely an
experiment. However, hereafter may be a more logical
explanation to oppose these theories.
Nowadays the media are flooded with images
of how humanity deals with the Ebola virus. It is obvi-
Journal of Molecular Biochemistry (2014) 3, 72-76 © The Author(s) 2014. Published by Lorem Ipsum Press.
ous that the range of Ebola cases depends on the pre-
ventive and dealing measures (Muyembe-Tamfum et
al. 1999). In developing countries, due to the lack of
education, expertise and health care, there is a high
transmission and mortality rate. Doctors there do not
have the appropriate medical equipment. They are not
able to run full tests. They do not have the expertise to
treat this epidemic or even to control its spread. People
diagnosed with Ebola should be kept in quarantine in-
dividually, but in West Africa there are barely any
main hospital units. As a result of these, if scientists
have the slightest suspicion of the virus infection in
people “they imprison them in the same cage” (Fowler
et al. 2014).
Culture and traditions can sometimes also
play dramatic roles towards this direction. For in-
stance, several funeral and/or burial rituals require
physical contact with the body of the deceased, even if
he/she has died from Ebola. Physical contact is a cru-
cial communication code among west Africans
(Dowell et al. 1999). Religious beliefs could also aid
in this direction.
On the other hand, developed countries have
all the resources to avoid this epidemic. People can get
informed on how to protect themselves and disease
symptoms are widely known. They have the necessary
educational level in order to resort immediately to
medical aid protecting their health and not putting oth-
ers in risk. In Europe and America, there are special-
ized treatment and hemodialysis units in hospitals.
These countries also have the financial background to
support expensive patient medication (Nagata 2014).
The origin of Ebola
Another subject that may cause a plethora of argu-
ments is that this virus may be a laboratory generated
virus. It may be assumed that all these could be a con-
spiracy or scaremongering theory. Nevertheless, scien-
tists do not know much about this virus except a few
basic characteristics. The virus depletes the body's im-
mune cells and its organs (Sullivan et al. 2011). Not-
withstanding the high fatality rates, there are some
people who survive and recover completely from
EVD’s infections. Furthermore, several research pro-
jects have led to the conclusion that some people may
be explicitly resistant to Ebola infections due to a mu-
tation in the NPC1 gene (Cote et al. 2011). Yet, we
barely know anything about this virus.
For example, it is not completely clear how
Ebola is transmitted. There is a conjecture that the vi-
rus is transmitted to people from wild animals. How-
ever, by reason of the high mortality among them, it is
impossible that these animals are the reservoir host of
EVD. The conviction is that fruit bats of the pteropodi-
dae family are natural Ebola virus hosts even though
the reservoir of EVD has not yet been identified
(Groseth et al. 2007). It is also believed that, among
73 Journal of Molecular Biochemistry, 2013
Figure 1. World prevalence of Ebola outbreak. Data are totals and only include confirmed cases (colored blue) and case deaths
(colored red). Data are based on official information reported by the Ministries of Health up to October 14 2014 (WHO, 2014).
humans, EVD can be disseminated through direct con-
tact with blood or body fluids such as sweat, urine,
breast milk, saliva and vomit of an infected person
(Francesconi et al. 2003).
There are some not well known dark sides of
EVD though, such as the potential use in biological
warfare. This encompasses the use of biological infec-
tious agents as weapons in order to nullify or extermi-
nate humans, animals or plants. The target can range
from one single individual to an entire population.
Based on the merits, biological warfare represents an
act of an invisible war. In these battlefields there is no
need of troop reinforcements or heavy weapons. These
wars do not require colossal financial resources, due to
the fact that a biological weapon acts underground and
it can be transferred easily through water, through the
ground or through the air without being perceived by
anybody.
So the ability to disseminate disease through
aerosol or airborne small-droplet nuclei would render
filoviruses a potential biologic warfare threat
(Salvaggio & Baddley 2004). According to some re-
searchers who have been involved with Soviet biologi-
cal weapons, Ebola and some other viruses have been
already weaponized in this manner by the former So-
viet Union (Miller et al. 2002). Aerosol transmission
of EVD has been demonstrated in experimental models
involving nonhuman primates (Borio et al. 2002). Dur-
ing an experiment to evaluate the benefits of interferon
treatment following infection with EBO-Z, two out of
three control rhesus monkeys became ill. Researchers
were unable to document direct or percutaneous con-
tact through injections, and speculated that inoculation
to the control animals occurred via pulmonary, naso-
pharyngeal, oral or conjunctival routes (Jaax et al.
1995). Definitive evidence that small-droplet nuclei
pose a substantial transmission risk among humans
during naturally occurring outbreaks is lacking. After
making a quick comparison of the number of cases
between this outbreak and previous ones, one could
argue that something is different this time (Salvaggio
& Baddley 2004). Is this epidemic disease a genuine
natural disaster or something else?
Diagnosis, treatment and EBOV proteins
In accordance with what is known so far, the
symptoms occur between 2 to 21 days after the infec-
tion. Typically, early symptoms include fever, head-
ache, weakness, stomach disorders, joint and muscle
pains (Bwaka et al. 1999). At a later stage, the patient
may present cough, breathing difficulties, hiccups,
bloodshot eyes and internal-external bleeding. There is
no treatment or vaccines to date. Hence, every research
project on this virus will constitute a significant pro-
gress towards the identification of Ebola’s mecha-
nisms.
The diagnosis of Ebola’s infection is labor-
intensive, as its symptoms are similar to other diseases,
such as cholera and malaria. Even the symptoms of a
common flu can be confused with those of Ebola. Di-
agnostic methods include CBC, electrolytes, blood
tests, liver tests and virus-specific antibodies (Tigabu
et al. 2009). The genome of EBOV is roughly 19 kb
long. It encodes seven structural proteins; RNA poly-
merase, nucleoprotein (NP), polymerase cofactors
VP35 and VP40, GP as well as transcription activators
VP30 and VP24 (Huang et al. 2002). It has been
shown from a plethora of research projects that this
protein is an antagonist of type one interferons and that
VP35 interacts with the IRF-3 kinases IKKε and TBK-
1. Its function is to prevent the establishment of a cel-
lular antiviral state by blocking virus-induced phos-
phorylation and triggering the activation of the inter-
feron regulatory factor 3 (IRF3) (Basler et al. 2003).
IRF3 is a transcription factor which plays a significant
role in the induction of interferons alpha and beta (IFN
-α/β).VP35 possesses a carboxy-terminal domain with
a unique fold that allows double-stranded RNA
(dsRNA) binding (Cardenas et al. 2006). This may be
a necessary function for the inhibition of IFN-α/β pro-
duction. Furthermore, VP35 mutants missing the
coiled-coil motif or carrying a mutation designed to
disrupt coiled-coil function were defective in the for-
mation of an oligomer. Of note, VP35 is also related
with the H1N1 and Margburg virus (Basler et al.
2000). In contrast, we do not know if VP35 is phos-
phorylated, although it is thought to share the function
of the phosphorylated proteins of rhabdoviruses and
paramyxoviruses due to its position in the genome.
Future directions
The full crystal structure of the Zaire EBOV
VP35 is not available yet. However, only recently the
structure of the Zaire EBOV VP35 interferon inhibi-
tory domain (IID) has been established. In the free
form the Zaire EBOV VP35 IID bounds to dsRNA.
VP35 IID forms a unique fold with 2 basic residue
clusters. One of these clusters is important for dsRNA
binding (Leung et al. 2010). The cluster of dsRNA that
function to bind is centered on Arg-312. It is a required
conserved residue for IFN inhibition. The C-terminal
cluster of basic amino acids of Ebola virus VP35 is a
prerequisite in order to bind the dsRNA with the inter-
feron regulatory factor 3 (IRF3) and inhibit its func-
tionality. Finally, VP35 is assumed to block and re-
verse the activation of protein kinase R (PKR).
Journal of Molecular Biochemistry, 2013 74
There is a dear need for a full structural 3D
model of VP35 (Carvalho et al. 2013, Dalkas et al.
2013, Vlachakis et al. 2014, Vlachakis & Kossida,
2013). There are preliminary indications of allosteric
sites on its structural domains, which could be ex-
ploited for the designing customized drug-like inhibi-
tors (Vlachakis et al. 2014, Loukatou et al. 2014, Pa-
pangelopoulos et al. 2014, Papageorgiou et al. 2014,
Sellis et al. 2009, Vangelatos et al. 2009). Funds must
be allocated towards the functional and biochemical
characterization of viral proteins such as VP35, which
constitute necessary machinery for Ebola’s virulence.
It is absolutely crucial to dig deeper, investigate and
understand the molecular mechanisms, which underlie
the rather complicated nature of this viral species.
Conficts of Interest
The authors declare no conflicts of interest.
References
Basler CF, Mikulasova A, Martinez-Sobrido L, Para-
gas J, Muhlberger E, Bray M, Klenk HD, Palese P &
Garcia-Sastre A 2003 The Ebola virus VP35 protein
inhibits activation of interferon regulatory factor 3. J
Virol 77 7945-7956
Basler CF, Wang X, Muhlberger E, Volchkov V, Para-
gas J, Klenk HD, Garcia-Sastre A & Palese P 2000
The Ebola virus VP35 protein functions as a type I
IFN antagonist. Proc Natl Acad Sci U S A 97 12289-
12294
Borio L, Inglesby T, Peters CJ, Schmaljohn AL,
Hughes JM, Jahrling PB, Ksiazek T, Johnson KM,
Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Bre-
man JG, Eitzen EM Jr, Hamburg M, Hauer J, Hender-
son DA, Johnson RT, Kwik G, Layton M, Lillibridge
S, Nabel GJ, Osterholm MT, Perl TM, Russell P, To-
nat K & Working Group on Civilian Biodefense 2002
Hemorrhagic fever viruses as biological weapons:
Medical and public health management. JAMA 287
2391-2405
Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De
Roo A, Guimard Y, Katwiki KR, Kibadi K, Kipasa
MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa
KD, Muyembe-Tamfum JJ, Ndaberey E, Peters CJ,
Rollin PE, Van den Enden E & Van den Enden E
1999 Ebola hemorrhagic fever in Kikwit, Democratic
Republic of the Congo: clinical observations in 103
patients. J Infect Dis 179 S1-7
Cardenas WB, Loo YM, Gale M Jr, Hartman AL,
Kimberlin CR, Martinez-Sobrido L, Saphire EO &
Basler CF 2006 Ebola virus VP35 protein binds dou-
ble-stranded RNA and inhibits alpha/beta interferon
production induced by RIG-I signalling. J Virol 80
5168-5178
Carvalho CS, Vlachakis D, Tsiliki G, Megalooikono-
mou V & Kossida S 2013 Protein signatures using
electrostatic molecular surfaces in harmonic space
PeerJ 1 e185
Cote M, Misasi J, Ren T, Bruchez A, Lee K, Filone
CM, Hensley L, Li Q, Ory D, Chandran K & Cunning-
ham J 2011 Small molecule inhibitors reveal Niemann-
Pick C1 is essential for Ebola virus infection. Nature
477 344-348
Dalkas GA, Vlachakis D, Tsagkrasoulis D, Kastania A
& Kossida S 2013 State-of-the-art technology in mod-
ern computer-aided drug design. Brief Bioinform 14
745-752
Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin
PE & Peters CJ 1999 Transmission of Ebola hemor-
rhagic fever: a study of risk factors in family members,
Kikwit, Democratic Republic of the Congo, 1995.
Commission de Lutte contre les Epidemies a Kikwit. J
Infect Dis 179 S87-91
Fowler RA, Fletcher T, Fischer WA 2nd, Lamontagne
F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA,
Houlihan C, O'Dempsey T, Ferri M, Adachi T, Lamah
MC, Bah EI, Mayet T, Schieffelin J, McLellan SL,
Senga M, Kato Y, Clement C, Mardel S, Vallenas Be-
jar De Villar RC, Shindo N & Bausch D 2014 Caring
for critically ill patients with ebola virus disease. Per-
spectives from west Africa. Am J Respir Crit Care
Med 190 733-737
Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani
M, Olango J, Andraghetti R, Rollin PE, Opira C,
Greco D & Salmaso S 2003 Ebola hemorrhagic fever
transmission and risk factors of contacts, Uganda.
Emerg Infect Dis 9 1430-1437
Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ,
Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G,
Wohl S, Moses LM, Yozwiak NL, Winnicki S, Ma-
tranga CB, Malboeuf CM, Qu J, Gladden AD, Schaff-
ner SF, Yang X, Jiang PP, Nekoui M, Colubri A,
Coomber MR, Fonnie M, Moigboi A, Gbakie M,
Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J,
Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo
K, Foday M, Yillah M, Kanneh F, Robert W, Massally
JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum
C, Young S, Birren BW, Grant DS, Scheiffelin JS,
Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut
A, Garry RF, Khan SH & Sabeti PC 2014 Genomic
surveillance elucidates Ebola virus origin and trans-
mission during the 2014 outbreak. Science 345 1369-
1372
Gomes MFC, Pastore y Piontti A, Rossi L, Chao D,
Longini I, Halloran ME & Vespignani A 2014 Assess-
ing the International Spreading Risk Associated with
75 Journal of Molecular Biochemistry, 2013
the 2014 West African Ebola Outbreak. PLOS Cur
Outbreak Edition 1
Groseth A, Feldmann H & Strong JE 2007 The ecol-
ogy of Ebola virus. Trends Microbiol 15 408-416
Gulland A 2014 Spanish authorities investigate how
nurse contracted Ebola. BMJ 349 g6120
Huang Y, Xu L, Sun Y & Nabel GJ 2002 The assem-
bly of Ebola virus nucleocapsid requires virion-
associated proteins 35 and 24 and posttranslational
modification of nucleoprotein Mol Cell 10 307-316
Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K,
McKee K, Nagley D, Johnson E, Jaax G & Peters C
1995 Transmission of Ebola virus (Zaire strain) to un-
infected control monkeys in a biocontainment labora-
tory. Lancet 346 1669-1671
Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson
KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov
SV, Nichol ST, Palacios G, Peters CJ, Tenorio A,
Volchkov VE & Jahrling PB 2010 Proposal for a re-
vised taxonomy of the family Filoviridae: classifica-
tion, names of taxa and viruses, and virus abbrevia-
tions Arch Virol 155 2083-2103
Leung DW, Prins KC, Borek DM, Farahbakhsh M,
Tufariello JM, Ramanan P, Nix JC, Helgeson LA, Ot-
winowski Z, Honzatko RB, Basler CF & Amarasinghe
GK 2010 Structural basis for dsRNA recognition and
interferon antagonism by Ebola VP35. Nat Struct Mol
Biol 17 165-172
Loukatou S, Papageorgiou L, Fakourelis P, Filtisi A,
Polychronidou E, Bassis I, Megalooikonomou V,
Makalowski W, Vlachakis D & Kossida S 2014 Mo-
lecular dynamics simulations through GPU video
games technologies. J Mol Biochem 3 64-71
McCarthy M 2014 Liberian man being treated for
Ebola in Texas dies. BMJ 349 g6145
Miller J, Engelberg S & Broad WJ 2002 Germs: Bio-
logical Weapons and America's Secret War: Simon &
Schuster
Muyembe-Tamfum JJ, Kipasa M, Kiyungu C & Cole-
bunders R 1999 Ebola outbreak in Kikwit, Democratic
Republic of the Congo: discovery and control meas-
ures. J Infect Dis 179 S259-262
Nagata N 2014 International Control of Epidemic Dis-
eases from a Historical and Cultural Perspective. In M.
Herren, ed, Networking the International System, pp.
73-88. Springer International Publishing.
Prevention, C. f. D. C. a. (October 13, 2014). Out-
breaks Chronology: Ebola Virus Disease.
Papangelopoulos N, Vlachakis D, Filtisi A, Fakourelis
P, Papageorgiou L, Megalooikonomou V & Kossida S
2014 State of the art GPGPU applications in bioinfor-
matics Int J Sys Biol Biomed Tech 2 24-48
Papageorgiou L, Vlachakis D, Koumandou VL, Pa-
pagelopoulos N & Kossida S 2014 Computer-aided
drug design and biological evaluation of novel anti-
Greek goat encephalitis agents. Int J Sys Biol Biomed
Tech 2 1-16
Salvaggio MR & Baddley JW 2004 Other viral
bioweapons: Ebola and Marburg hemorrhagic fever.
Dermatol Clin 22 291-302
Sellis D, Vlachakis D & Vlassi M 2009 Gromita: a
fully integrated graphical user interface to gromacs 4.
Bioinform Biol Ins 3 99-102
Sullivan NJ, Hensley L, Asiedu C, Geisbert TW,
Stanley D, Johnson J, Honko A, Olinger G, Bailey M,
Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M,
Jahrling PB, Koup RA & Nabel GJ 2011 CD8+ cellu-
lar immunity mediates rAd5 vaccine protection against
Ebola virus infection of nonhuman primates. Nat Med
17 1128-1131
Tigabu B, Juelich T, Bertrand J & Holbrook MR 2009
Clinical evaluation of highly pathogenic tick-borne
flavivirus infection in the mouse model. J Med Virol
81 1261-1269
Vangelatos I, Vlachakis D, Sophianopoulou V & Dial-
linas G 2009 Modelling and mutational evidence iden-
tify the substrate binding site and functional elements
in APC amino acid transporters. Mol Membrane Biol
26 356-370
Vlachakis D, Bencurova E, Papangelopoulos N &
Kossida S 2014 Current State-of-the-Art Molecular
Dynamics Methods and Applications. Adv Protein
Chem Struct Biol 94 269-313
Vlachakis D & Kossida S 2013 Molecular modeling
and pharmacophore elucidation study of the Classical
Swine Fever virus helicase as a promising pharmacol-
ogical target. PeerJ 1 e85
Vlachakis D, Pavlopoulou A, Roubelakis MG, Feida-
kis C, Anagnou NP & Kossida S 2014 3D molecular
modeling and evolutionary study of the Trypanosoma
brucei DNA Topoisomerase IB, as a new emerging
pharmacological target. Genomics 103 107-113.
Journal of Molecular Biochemistry, 2013 76
... Ebola menyebar Ketika seseorang berkontak langsung dengan darah manusia atau hewan yang terinfeksi ebola (NHS, 2021). Virus ebola sangat berpotensi untuk dijadikan senjata biologis dan dampaknya akan sangat berbahaya (Loukatou, et al., 2014). Wabah yang terjadi juga dapat berdampak buruk untuk lingkungan, seperti terjadinya kontaminasi dan polusi lingkungan. ...
Article
Full-text available
Indonesia adalah negara yang terletak di garis khatulistiwa. Indonesia juga merupakan negara yang sangat kaya dengan kekayaan alamnya. Dibalik kekayaan yang dimiliki, Indonesia memiliki berbagai ancaman yang mengancam pertahanan dan ketahanan Indonesia baik itu ancaman militer maupun ancaman non militer. Salah satu ancaman yang dapat menyerang Indonesia adalah ancaman bioterorisme. Penanganan yang tepat dari suatu wabah akibat bioterorisme menjadi hal yang penting untuk diperhatikan. Oleh karenanya hambatan dan tantangan terkait dengan penanganan agen biologis untuk bioterorisme perlu diketahui dan dianalisa. Metode penelitian yang dilakukan adalah pneelitian kualitatif dengan metode studi literatur. Agen biologis yang dapat digunakan sebagai senjata bioterorisme diantaranya mencakup; Anthrax, Flu Burung, Ebola. Bioterorisme memiliki dampak yang luas baik dari segi ekonomi, sosial, budaya hingga lingkungan ekosistem. Sampai saat ini di Indonesia, tidak ada kasus bioterorisme yang terjadi secara langsung. Namun hal tersebut tidak menutup kemungkinan kasus bioterorisme dapat terjadi di Indonesia dikemudian hari. Indonesia sendiri masih belum ada protokol secara hukum yang jelas, terkait dengan serangan agensia biologi yang mungkin terjadi. Indonesia pun sampai saat ini masih belum ada lembaga spesifik yang berkaitan langsung dan berfokus pada penanganan bioterorisme dan wabah penyakit. Tentunya lembaga tersebut butuh dasar hukum yang jelas, sehingga dalam pekerjaanya lembaga tersebut terlindungi undang-undang.
... The first dangerous conspiracy theory was that Ebola was a real disease, which had been manufactured deliberately by actors such as the U.S. military or in some other nation's military lab. 13,14 For example, in 2014 Alan Feur published a piece in the New York Times, titled "The Ebola Conspiracy Theories," in which he described the narratives circulating around the virus: "The outbreak began in September, when The Daily Observer, a Liberian newspaper, published an article alleging that the virus was not what it seemed -a medical disaster -but rather a bioweapon designed by the United States military to depopulate the planet." 15 Many similar narratives circulated in West Africa (as documented in the region's press), which described a cabal of external actors that had created Ebola. ...
Article
Full-text available
The public health campaign against Ebola in the Democratic Republic of the Congo faced serious challenges, some due to conspiracy theories and denial. These beliefs were so powerful that they even caused repeated attacks upon health care providers and medical centers. These conspiracy theories were nothing new, as they are a common feature of all frightening epidemics, such as HIV and COVID-19. These narratives also circulated during the 2015 West African Ebola outbreak. Addressing conspiracy theories during an epidemic requires a coordinated campaign involving not only local leaders but also the cooperation of social media organizations.
... For example, HIV/AIDS was long speculated to be a foreign disease in some regions in the absence of a strong and effective public health communication (Stadler, 2003). Similarly, there was a notion that Ebola was a laboratory-generated virus (Loukatou et al., 2014). During the influenza (HS5N1) epidemic in 2004, WHO identified 40 different rumours in circulation, only nine of which were verified to be factually correct (Samaan et al., 2005). ...
Article
The novel coronavirus disease 2019 (COVID-19), which was first identified in Wuhan city, China, in late December 2019, has now spread globally with over 43 million people infected and about 1.16 million deaths as of 30 October 2020. COVID-19 is a novel and highly transmissible disease where little is known, which is why health authorities and the public alike have reasons to be concerned. With the spread of the disease, there has been an ‘infodemic’, which is defined as an influx of all kinds of information, including authentic information and also rumours, misinformation and conspiracy theories about the origin, prevention and treatment of the disease. With the growth of infodemics over social media and mass media, prejudicial and xenophobic acts became more evident, presenting additional challenges for health authorities. Effective control of pandemics such as COVID-19 thus requires large-scale, multifaceted response measures including risk communications. A transdisciplinary collaborative One Health approach has been increasingly advocated as an effective strategy to address diseases that occur at the human-animal-ecosystem interface. Similarly, the role of social science in risk communications in recent epidemics such as Ebola has been widely acknowledged. Timely interdisciplinary reviews, including a social and behavioural sciences lens, are needed to optimise the pandemic response through effectively combating communication challenges associated with infodemics and many other challenges in future epidemic responses. Keywords: infodemic, coronavirus, pandemic, misinformation, One Health, whole-of-government pandemic plan, social science, risk communications
... [5,6]. Adding to SARS, MERS, and COVID-19 are other recent viral but non CoVs disease outbreaks; H1N1 Swine flu that emerged from Mexico and USA in 2009 [7] and Ebola from West Africa in 2014 [8] are also worth mentioning based on their ability to re-emerge and affect large populations (Figure 1.2). Transmission of the viruses is quite possible between humans, animals and the environment (water, soil, air, plants and inanimate objects). ...
Article
Full-text available
The COVID-19 pandemic poses an enormous challenge, and it is evidently presenting itself as one of the greatest threats to humanity. The aim of this paper is to review the current state of the COVID-19 pandemic, the global health impact and implications of COVID-19 relative to other recent viral disease outbreaks and antimicrobial resistance (AMR), with the aim to propose the implementation of sustainable solutions. The magnitude of COVID-19 deaths is incomparable to other coronaviruses (CoVs) disease outbreaks experienced in recent history. The high number of deaths observed in developed countries compared to developing countries may have been triggered by the late response/preparedness to the pandemic rather than by the socio-economic statuses. CoVs will remain a serious health threat to humanity due to absence of vaccines and anti-viral treatments. The absence of specific treatment regimens also lead to heavy reliance on chemical disinfectants and could significantly contribute to the rise in AMR, further raising some important questions surrounding hygiene, microbes, ecosystem health and human diseases. The CEASE approach, comprising of five key elements; Communication, Education, Advocacy, Socialization, and Experimentation is proposed for implementation at a global level. CEASE approach is critical especially for African countries and can be used to further explore opportunities that can lead to improvements in sanitation, access to clean water, health care, education and infectious disease surveillance systems.
... In the face of such uncertainty, people struggle to find meaning, and their attempts to do so can be exploited by the proffering of "fake news," perhaps for political gain. In Sierra Leone, beliefs concerning the Ebola virus included that it had been deliberately spread by the government, by hostile regimes, or by scientists (Loukatou et al., 2014), and similar myths abound concerning COVID-19 (Shan-Lu et al., 2020), including the claim that 5 G networks are contributing to the spread of the virus (Morgan, 2020). In both of these epidemics, there have been instances of such myths leading to assaults on, or ostracism of, people who are construed as potential carriers of the virus (Ellis-Peterson, 2020; Russell, 2020;Spring, 2020;Winter, 2018), including workers involved in the care of those who have been infected. ...
Article
Responses to the COVID-19 pandemic are considered in terms of personal construct theory, including the diagnostic constructs proposed by George Kelly. The pandemic is seen to have caused transitions in people’s construing, experienced, for example, as anxiety, threat, guilt, and shame; and strategies to cope with it have included constriction and hostility. The reactions both of individuals and of governments differ, reflecting the individuality of construing, and can be usefully viewed in terms of personal construct perspectives on choice and decision-making. Losses resulting from the pandemic may be dealt with by a process of meaning reconstruction, and alternative constructions of it may usefully include consideration of positive changes that it has brought about, including reevaluation of the superordinate constructs of individuals and societies.
... Among them, the irst four cause disease in humans. The disease has a high risk of death, killing between 25 and 90% of those infected, with an average of about 50% [57]. The disease was irst identiied in 1976 in two simultaneous outbreaks, one in Nzara and the other in Yambuku, a village near the Ebola River from which the disease took its name. ...
Article
Full-text available
This study presents the experiences of the Ghanaian people toward the COVID-19 global pandemic. It presents the popular views and attitudes of the people of Ghana on the socio-cultural, economic and educational implications of the COVID-19. The data for the study are based on news reports on television and radio stations as well as print media. Also, data were generated from twenty seven personal interviews via face-to-face, telephone and zoom video interactions. The data were discussed using thematic analysis as well as document analysis in the qualitative research approach. The findings revealed that the emergence of the COVID-19 pandemic in Ghana came as a shock to many Ghanaians who held the popular view that the virus was immune to black genes. Some Ghanaians believe that the infection is a matter of faith and prioritize religious supplications as a protective metric than the strict adherence to the medical preventive protocols for the COVID-19. The intensive public education and the laudable efforts by the Ghana government are gradually erasing these wrong perceptions toward the COVID-19 infection.
Article
Full-text available
At the end of the 1980s, the hepatitis C virus (HCV) was cloned and formally identified as the cause of the majority of non-A and non-B hepatitis cases. Today, around 170 million people worldwide are infected with HCV, making it five times more common than infec-tion with the human immunodeficiency virus (HIV). Several methods exist which mediate the spread of infection. One of the most common and efficient is sharing or re-using injecting equipment; studies have indicated that 80-90% of individuals in some popula-tions of intravenous drug users test positive in serum HCV assays. Contracting HCV from infected blood transfusions was also a major cause of infection before screening tests were introduced in the early 1990s. Other possible, but less common, methods of infection transmission include mother-to-child during pregnan-cy, sexual contact and nosocomial acquisition (for ex-ample between surgical or dialysis patients). It ap-pears that concurrent HIV-1 infection increases the risk of HCV transmission via the mother-to-child or sexual routes.
Article
Full-text available
The largest ever Ebola virus disease outbreak is ravaging West Africa. The constellation of little public health infrastructure, low levels of health literacy, limited acute care and infection prevention and control resources, densely populated areas, and a highly transmissible and lethal viral infection have led to thousands of confirmed, probable, or suspected cases thus far. Ebola virus disease is characterized by a febrile severe illness with profound gastrointestinal manifestations and is complicated by intravascular volume depletion, shock, profound electrolyte abnormalities, and organ dysfunction. Despite no proven Ebola virus-specific medical therapies, the potential effect of supportive care is great for a condition with high baseline mortality and one usually occurring in resource-constrained settings. With more personnel, basic monitoring, and supportive treatment, many of the sickest patients with Ebola virus disease do not need to die. Ebola virus disease represents an illness ready for a paradigm shift in care delivery and outcomes, and the profession of critical care medicine can and should be instrumental in helping this happen.
Article
Full-text available
is the scientific field that focuses on the application of computer technology to the management of biological information. Over the years, bioinformat-ics applications have been used to store, process and integrate biological and genetic information, using a wide range of methodologies. One of the most de novo techniques used to understand the physical movements of atoms and molecules is molecular dynamics (MD). MD is an in silico method to simulate the physical motions of atoms and molecules under certain conditions. This has become a state strategic technique and now plays a key role in many areas of exact sci-ences, such as chemistry, biology, physics and medi-cine. Due to their complexity, MD calculations could require enormous amounts of computer memory and time and therefore their execution has been a big prob-lem. Despite the huge computational cost, molecular dynamics have been implemented using traditional computers with a central memory unit (CPU). A graphics processing unit (GPU) computing technology was first designed with the goal to improve video games, by rapidly creating and displaying imag-es in a frame buffer such as screens. The hybrid GPU-CPU implementation, combined with parallel compu-ting is a novel technology to perform a wide range of calculations. GPUs have been proposed and used to accelerate many scientific computations including MD simulations. Herein, we describe the new methodolo-gies developed initially as video games and how they are now applied in MD simulations.
Article
Full-text available
Background: The 2014 West African Ebola Outbreak is so far the largest and deadliest recorded in history. The affected countries, Sierra Leone, Guinea, Liberia, and Nigeria, have been struggling to contain and to mitigate the outbreak. The ongoing rise in confirmed and suspected cases, 2615 as of 20 August 2014, is considered to increase the risk of international dissemination, especially because the epidemic is now affecting cities with major commercial airports. Method: We use the Global Epidemic and Mobility Model to generate stochastic, individual based simulations of epidemic spread worldwide, yielding, among other measures, the incidence and seeding events at a daily resolution for 3,362 subpopulations in 220 countries. The mobility model integrates daily airline passenger traffic worldwide and the disease model includes the community, hospital, and burial transmission dynamic. We use a multimodel inference approach calibrated on data from 6 July to the date of 9 August 2014. The estimates obtained were used to generate a 3-month ensemble forecast that provides quantitative estimates of the local transmission of Ebola virus disease in West Africa and the probability of international spread if the containment measures are not successful at curtailing the outbreak. Results: We model the short-term growth rate of the disease in the affected West African countries and estimate the basic reproductive number to be in the range 1.5 − 2.0 (interval at the 1/10 relative likelihood). We simulated the international spreading of the outbreak and provide the estimate for the probability of Ebola virus disease case importation in countries across the world. Results indicate that the short-term (3 and 6 weeks) probability of international spread outside the African region is small, but not negligible. The extension of the outbreak is more likely occurring in African countries, increasing the risk of international dissemination on a longer time scale.
Article
Full-text available
The exponential growth of available biological data in recent years coupled with their increasing complexity has made their analysis a computationally challenging process. Traditional central processing unist (CPUs) are reaching their limit in processing power and are not designed primarily for multithreaded applications. Graphics processing units (GPUs) on the other hand are affordable, scalable computer powerhouses that, thanks to the ever increasing demand for higher quality graphics, have yet to reach their limit. Typically high-end CPUs have 8-16 cores, whereas GPUs can have more than 2,500 cores. GPUs are also, by design, highly parallel, multicore and multithreaded, able of handling thousands of threads doing the same calculation on different subsets of a large data set. This ability is what makes them perfectly suited for biological analysis tasks. Lately this potential has been realized by many bioinformatics researches and a huge variety of tools and algorithms have been ported to GPUs, or designed from the ground up to maximize the usage of available cores. Here, we present a comprehensive review of available bioinformatics tools ranging from sequence and image analysis to protein structure prediction and systems biology that use NVIDIA Compute Unified Device Architecture (CUDA) general-purpose computing on graphics processing units (GPGPU) programming language.
Article
Full-text available
The Flaviviridae family of viruses infects vertebrates and is primarily spread through arthropod vectors. The Greek Goat Encephalitis (GGE) flavivirus belongs to the Flaviviridae family and specifically to the genus Flavivirus. GGE virus, which is endemic in Greece, is the causative agent of tick-borne encephalitis (TBE), an infection of the central nervous system that can be transmitted from animals to humans by ticks. Although, there are very limited data regarding the GGE virus and its epidemiology in Greece, there have been few reported cases of GGE viral infection of goats in northern Greece. However, despite the severity of Flaviviridae causing diseases (e.g. Hepatitis C, Dengue fever, Yellow fever, Classical swine fever, Japanese encephalitis), currently there is not any available anti-flaviviridae therapy. Thus, there is a need for the development of effective anti-GGE viral pharmaceutical strategies. It has been shown that RNA helicases, which are involved in duplex unwinding during viral RNA replication, represent promising antiviral targets. Therefore, we suggest that inhibition of the GGE viral helicase would be an effective approach of interrupting the life cycle of the GGE virus. Our proposed research will be directed towards the computer-aided development of a series of drug-like low molecular weight compounds capable of inhibiting the helicase enzyme of GGE virus. Results derived from a repertoire of multi-disciplinary bioinformatics and statistical methods would enhance our understanding of the mechanism of action of the GGE viral helicase enzyme. Our ultimate goal is to design a series of novel anti-helicase compounds as drug candidates against the endemic GGE virus while the inhibitory activity of our novel compounds will be evaluated biologically.
Chapter
In the globalized world the transnational movement of people has increased, with the consequence that people have become more exposed to threats from various epidemic diseases. Not only have cholera, plague, and yellow fever reappeared but also Ebola, HIV, BSE, SARS, and recently avian flu have newly emerged in the world. Now swine flu too has become a threat to life.
Article
A Liberian man who fell ill with Ebola shortly after arriving in the United States has died, officials at the Texas hospital where he was being treated announced on Wednesday 8 October. Thomas Eric Duncan, a 42 year old Liberian national, left Liberia on 19 September, arriving in Dallas, Texas the next day.1 Press reports said that he had helped to carry a young woman who was ill with Ebola several weeks earlier but had not had symptoms of infection while en route to the US. Liberian health officials …
Article
Molecular dynamics simulations are used to describe the patterns, strength, and properties of protein behavior, drug-receptor interactions, the solvation of molecules, the conformational changes that a protein or molecule may undergo under various conditions, and other events that require the systematic evaluation of molecular properties in dynamic molecular systems. Only few years ago proteins were considered to be rigid body structures with very limited conformational flexibility. However, it is now clear that proteins are highly dynamic structures, the internal organization of which is the key to their 3D spatial arrangement and hence biological function. The study of protein dynamics in the lab is a very complicated, expensive, and time-consuming process. Therefore, a lot of effort and hope lies with the computers and the in silico study of protein structure and molecular dynamics. Herein, an effort has been made to describe the ever-evolving field of molecular dynamics, the different algorithms, and force fields that are being used as well as to provide some insight on what the near future holds for this auspicious field of computational structural biology.
Article
In the present study, an outline is proposed that may lead to specific drug design targeting of the Trypanosoma brucei DNA Topoisomerase IB. In this direction, an unequivocally specific platform was designed for the development of selective modulators. The designed platform is focused on the unique structural and catalytic features of the enzyme. Extensive phylogenetic analysis based on all available published genomes indicated a broad distribution of DNA topoisomerases across eukaryotic species and revealed structurally important amino acids which could be assigned as potentially strong contributors to the regulation of the mechanism of the Trypanosoma brucei DNA Topoisomerase IB. Based on the above, we propose a comprehensive in silico 3D model for the structure of the Trypanosoma brucei DNA Topoisomerase IB. Our approach provides an efficient intergraded platform with both evolutionary and structural insights for the rational design of pharmacophore models as well as novel modulators as the anti-Trypanosoma brucei DNA Topoisomerase IB agents with therapeutic potential.